BCL2 and B-cell non-Hodgkin lymphoma: Possible contributing mechanisms include partial expression of drug efflux transporters (e.g., P-glycoprotein), B-cell lymphoma (Bcl-2) overexpression, impaired p53-dependent apoptosis, and the existence of a stem-like subpopulation.